KYMR - Kymera Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Kymera Therapeutics, Inc.
IPO Date: August 21, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $9.09B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.41 | 3.25%
Avg Daily Range (30 D): $1.98 | 1.71%
Avg Daily Range (90 D): $2.66 | 2.51%
Institutional Daily Volume
Avg Daily Volume: .48M
Avg Daily Volume (30 D): .57M
Avg Daily Volume (90 D): .65M
Trade Size
Avg Trade Size (Sh.): 53
Avg Trade Size (Sh.) (30 D): 44
Avg Trade Size (Sh.) (90 D): 48
Institutional Trades
Total Institutional Trades: 3,281
Avg Institutional Trade: $3.01M
Avg Institutional Trade (30 D): $6.24M
Avg Institutional Trade (90 D): $5.37M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.7M
Avg Closing Trade (30 D): $18.07M
Avg Closing Trade (90 D): $16.17M
Avg Closing Volume: 98.15K
 
News
Jul 12, 2026 @ 8:37 PM
Kymera's CEO Sold $6 Million in Stock After a 170%...
Source: Jonathan Ponciano
Jun 12, 2026 @ 11:00 AM
Kymera Therapeutics Presents Phase 1 Data in Healt...
Source: Na
Jun 8, 2026 @ 11:00 AM
Kymera Therapeutics Presents New Preclinical Lupus...
Source: Kymera Therapeutics
May 15, 2026 @ 11:00 AM
Kymera Therapeutics Announces Presentations on KT-...
Source: Na
May 6, 2026 @ 11:00 AM
Kymera Therapeutics to Participate in Upcoming May...
Source: Not Specified
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-3.25 $-.62 $-.71
Diluted EPS $-3.25 $-.62 $-.71
Revenue $105M $65M $34.37M
Gross Profit $M $M $M
Net Income / Loss $-299.6M $-61.21M $-69.23M
Operating Income / Loss $-350.18M $-75.61M $-84.16M
Cost of Revenue $105M $65M $34.37M
Net Cash Flow $-211.34M
PE Ratio